Question follow-through · 17691

Veterans: Mefloquine

To ask the Secretary of State for Defence, if he will ensure that the MOD Defence Medical Service updates its policy on Mefloquine-damaged veterans to (a) acknowledge the recent confirmation by NHS England that Mefloquine neurotoxicity (i) exists and (ii)

answeredMinistry of Defence

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Ministry of Defence
Tabled
10 Jul 2026
Target answer date
15 Jul 2026
Answer
15 Jul 2026 · 5 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 10 Jul 2026

    Question tabled

    To ask the Secretary of State for Defence, if he will ensure that the MOD Defence Medical Service updates its policy on Mefloquine-damaged veterans to (a) acknowledge the recent confirmation by NHS England that Mefloquine neurotoxicity (i) exists and (ii)

  2. 15 Jul 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 15 Jul 2026

    Answer published

    I refer the hon. member to the answer provided by the Department of Health and Social Care (DHSC) in January this year. https://questions-statements.parliament.uk/written-questions/detail/2026-01-12/104605 The Ministry of Defence (MOD) and DHSC recognise ...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

No later same-department questions indexed.

This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.